Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N4FX
|
||||
Drug Name |
Ranolazine extended-release
|
||||
Synonyms |
CVT 303; CVT 3041; KEG 1295; RAN D; Ran4; Ranexa; Ranolazine hydrochloride; RS 43285; RS 43285-003; RS 43285-193
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Unspecified | Approved | [551871] | ||
Therapeutic Class |
Cardiovascular Agents
|
||||
Formula |
C24H33N3O4
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Plasminogen | Target Info | Modulator | [532368] | |
PANTHER Pathway | Blood coagulation | ||||
Plasminogen activating cascade | |||||
PathWhiz Pathway | Coagulation | ||||
WikiPathways | Complement and Coagulation Cascades | ||||
Human Complement System | |||||
Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | |||||
Activation of Matrix Metalloproteinases | |||||
Blood Clotting Cascade | |||||
Dissolution of Fibrin Clot | |||||
Folate Metabolism | |||||
Vitamin B12 Metabolism | |||||
Selenium Micronutrient Network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.